Augmedix, Inc. Common Stock
AUGX
AUGX was delisted on the 1st of October, 2024.
29 hedge funds and large institutions have $34.4M invested in Augmedix, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 2 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
25% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 8
4% more funds holding
Funds holding: 28 → 29 (+1)
2% more capital invested
Capital invested by funds: $33.8M → $34.4M (+$564K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$1.57M |
| 2 |
SC
Samjo Capital
New York
|
+$1.08M |
| 3 |
CPA
Cowen Prime Advisors
New York
|
+$945K |
| 4 |
Boston Partners
Boston,
Massachusetts
|
+$36.9K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$36.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$33K |
| 2 |
TC
TownSquare Capital
Provo,
Utah
|
-$24.7K |
| 3 |
William Blair & Company
Chicago,
Illinois
|
-$8.31K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.6K |
| 5 |
FW
FirstPurpose Wealth
Orem,
Utah
|
-$2.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TCM
26
TD Capital Management
Memphis,
Tennessee
| $2.35K | – | – | – |
|
27
Wells Fargo
San Francisco,
California
| $1.84K | +$6 | +5 | +0.4% |
|
28
Morgan Stanley
New York
| $1.56K | – | – | – |
|
29
Bank of America
Charlotte,
North Carolina
| $46 | +$38 | +30 | New |
|
|
30
Citadel Advisors
Miami,
Florida
| – | -$33K | -23,090 | Closed |
|
AUGX Hedge Fund Activity: Q4 2022 in Review
29 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Augmedix, Inc. Common Stock (AUGX) for Q4 2022, worth a combined $34.4M — up 1.7% from $33.8M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new AUGX positions and 2 closed out — a net gain of 2 holders — while 10 added to existing stakes and 8 trimmed.
The largest buyer was Perkins Capital Management, adding an estimated $1.57M. The largest seller was Citadel Advisors, exiting entirely with an estimated $33K sold.
- 29 institutional investors held Augmedix, Inc. Common Stock (AUGX) as of Q4 2022, up from 28 in Q3 2022.
- Funds reported $34.4M of Augmedix, Inc. Common Stock stock for Q4 2022, up 1.7% quarter-over-quarter.
- 4 funds opened new Augmedix, Inc. Common Stock positions in Q4 2022 and 2 closed out, a net change of +2 holders.
- The largest Augmedix, Inc. Common Stock buyer in Q4 2022 was Perkins Capital Management, an estimated $1.57M added.
- The largest Augmedix, Inc. Common Stock seller in Q4 2022 was Citadel Advisors, an estimated $33K sold.
Based on aggregated 13F filings for Q4 2022.